Table of Content

1 INTRODUCTION 42
1.1 STUDY OBJECTIVES 42
1.2 MARKET DEFINITION 42
1.2.1 INCLUSIONS & EXCLUSIONS 43
1.3 STUDY SCOPE 43
1.3.1 MARKETS COVERED 43
1.3.2 YEARS CONSIDERED 44
1.4 CURRENCY 44
1.5 LIMITATIONS 44
1.6 STAKEHOLDERS 45
1.7 SUMMARY OF CHANGES 45
1.7.1 IMPACT OF ECONOMIC RECESSION 46
2 RESEARCH METHODOLOGY 47
2.1 RESEARCH DATA 47
FIGURE 1 RESEARCH DESIGN 47
2.1.1 SECONDARY DATA 48
2.1.2 PRIMARY DATA 48
FIGURE 2 BREAKDOWN OF PRIMARIES 49
2.2 MARKET ESTIMATION METHODOLOGY 50
FIGURE 3 CELL-BASED ASSAYS MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS 50
FIGURE 4 APPROACH 1: MARKET SIZE ESTIMATION – COMPANY REVENUE ANALYSIS (2022) 51
2.2.1 INSIGHTS FROM PRIMARY EXPERTS 52
FIGURE 5 MARKET SIZE VALIDATION FROM PRIMARY SOURCES 52
2.3 MARKET GROWTH RATE PROJECTIONS 53
FIGURE 6 CELL-BASED ASSAYS MARKET (SUPPLY SIDE): CAGR PROJECTIONS 53
FIGURE 7 CELL-BASED ASSAYS MARKET: GROWTH ANALYSIS OF DEMAND-SIDE FACTORS 54
2.3.1 MARKET BREAKDOWN AND DATA TRIANGULATION 55
FIGURE 8 DATA TRIANGULATION METHODOLOGY 55
2.4 STUDY ASSUMPTIONS 56
2.5 IMPACT OF RECESSION ON CELL-BASED ASSAYS MARKET 56
2.6 RISK ANALYSIS 57
?
3 EXECUTIVE SUMMARY 58
FIGURE 9 CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION) 58
FIGURE 10 CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 59
FIGURE 11 CELL-BASED ASSAYS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 59
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF CELL-BASED ASSAYS MARKET 60
4 PREMIUM INSIGHTS 61
4.1 CELL-BASED ASSAYS MARKET OVERVIEW 61
FIGURE 13 RISING DRUG DISCOVERY ACTIVITY TO DRIVE DEMAND FOR CELL-BASED ASSAYS 61
4.2 NORTH AMERICA: CELL-BASED ASSAYS MARKET SHARE (2022) 62
FIGURE 14 CONSUMABLES COMMANDED LARGEST SHARE OF NORTH AMERICAN CELL-BASED ASSAYS MARKET IN 2022 62
4.3 CELL-BASED ASSAYS MARKET SHARE, BY APPLICATION, 2022 VS. 2028 62
FIGURE 15 DRUG DISCOVERY SEGMENT TO CONTINUE TO DOMINATE MARKET IN 2028 62
4.4 CELL-BASED ASSAYS MARKET SHARE, BY END USER (2022) 63
FIGURE 16 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES ACCOUNTED FOR LARGEST MARKET SHARE IN 2022 63
4.5 CELL-BASED ASSAYS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 63
FIGURE 17 ASIA PACIFIC COUNTRIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 63
5 MARKET OVERVIEW 64
5.1 INTRODUCTION 64
5.2 MARKET DYNAMICS 64
FIGURE 18 CELL-BASED ASSAYS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 64
TABLE 2 CELL-BASED ASSAYS MARKET: IMPACT ANALYSIS 65
5.2.1 DRIVERS 65
5.2.1.1 Growing demand for drug discovery & development and increasing preference for cell-based assays in drug discovery 65
5.2.1.2 Government support and funding for cell-based research 66
TABLE 3 NIH FUNDING FOR CELL-BASED RESEARCH, 2019–2021 (USD MILLION) 67
5.2.1.3 Growing efforts by FDA to curtail animal-based studies 67
5.2.2 RESTRAINTS 68
5.2.2.1 High cost of instruments and restrictions imposed by product end-user licenses for reagents 68
5.2.2.2 Lack of standardization of protocols used in cell-based assays 69
5.2.3 OPPORTUNITIES 69
5.2.3.1 Growing applications of cell-based assays in chronic diseases and personalized medicine 69
5.2.3.2 Growing opportunities in emerging economies 70
5.2.4 CHALLENGES 71
5.2.4.1 Complexities in assay designs 71
5.3 IMPACT OF UNCERTAINTIES ON CELL-BASED ASSAYS MARKET 72
FIGURE 19 SPECTRUM OF SCENARIOS BASED ON IMPACT OF UNCERTAINTIES 72
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 73
FIGURE 20 REVENUE SHIFT AND NEW REVENUE POCKETS FOR CELL-BASED ASSAY PRODUCT PROVIDERS 73
5.5 PRICING ANALYSIS 73
5.5.1 AVERAGE SELLING PRICE OF PRODUCTS OFFERED BY KEY PLAYERS 73
TABLE 4 PRICE OF CELL-BASED ASSAY PRODUCTS, BY KEY PLAYER 73
5.5.2 AVERAGE SELLING PRICE TREND 73
5.6 VALUE CHAIN ANALYSIS 74
FIGURE 21 CELL-BASED ASSAYS MARKET: VALUE CHAIN ANALYSIS 74
5.7 SUPPLY CHAIN ANALYSIS 74
FIGURE 22 CELL-BASED ASSAYS MARKET: SUPPLY CHAIN ANALYSIS 75
5.8 ECOSYSTEM ANALYSIS 76
FIGURE 23 CELL-BASED ASSAYS MARKET: ECOSYSTEM ANALYSIS 76
TABLE 5 SUPPLY CHAIN ECOSYSTEM 76
5.9 TECHNOLOGY ANALYSIS 77
5.9.1 FLOW CYTOMETRY 78
5.9.2 HIGH-THROUGHPUT SCREENING (HTS) TECHNOLOGY 78
5.9.3 HIGH-CONTENT SCREENING (HCS) 78
5.9.4 LABEL-FREE DETECTION 79
5.10 REGULATORY ANALYSIS 80
5.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS IN DIFFERENT REGIONS/COUNTRIES 80
5.11 PORTER’S FIVE FORCES ANALYSIS 81
TABLE 6 CELL-BASED ASSAYS MARKET: PORTER’S FIVE FORCES ANALYSIS 81
5.11.1 THREAT OF NEW ENTRANTS 81
5.11.2 THREAT OF SUBSTITUTES 81
5.11.3 BARGAINING POWER OF BUYERS 81
5.11.4 BARGAINING POWER OF SUPPLIERS 82
5.11.5 INTENSITY OF COMPETITIVE RIVALRY 82
5.12 KEY CONFERENCES & EVENTS, 2022–2023 82
TABLE 7 CELL-BASED ASSAYS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 82
5.13 KEY STAKEHOLDERS & BUYING CRITERIA 83
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 83
FIGURE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF CELL-BASED ASSAYS 83
5.13.2 BUYING CRITERIA FOR CELL-BASED ASSAYS 83
FIGURE 25 KEY BUYING CRITERIA FOR END USERS 83
5.14 PATENT ANALYSIS 84
FIGURE 26 PATENT APPLICATIONS FOR CELL-BASED ASSAYS MARKET, JANUARY 2013–JUNE 2023 84
6 CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE 85
6.1 INTRODUCTION 86
TABLE 8 CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 86
6.2 CONSUMABLES 86
TABLE 9 CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY REGION, 2021–2028 (USD MILLION) 87
TABLE 10 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION) 87
TABLE 11 EUROPE: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION) 88
TABLE 12 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION) 88
TABLE 13 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION) 89
TABLE 14 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION) 89
TABLE 15 CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION) 90
6.2.1 REAGENTS 90
6.2.1.1 High demand for reagents in research applications to propel market growth 90
TABLE 16 CELL-BASED ASSAYS MARKET FOR REAGENTS, BY REGION, 2021–2028 (USD MILLION) 91
TABLE 17 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 91
TABLE 18 EUROPE: CELL-BASED ASSAYS MARKET FOR REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 92
TABLE 19 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 92
TABLE 20 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 93
TABLE 21 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 93
6.2.2 ASSAY KITS 93
TABLE 22 CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY REGION, 2021–2028 (USD MILLION) 94
TABLE 23 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY COUNTRY, 2021–2028 (USD MILLION) 94
TABLE 24 EUROPE: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY COUNTRY, 2021–2028 (USD MILLION) 95
TABLE 25 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY COUNTRY, 2021–2028 (USD MILLION) 95
TABLE 26 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY COUNTRY, 2021–2028 (USD MILLION) 96
TABLE 27 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY COUNTRY, 2021–2028 (USD MILLION) 96
TABLE 28 CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION) 96
6.2.2.1 Reporter gene assays 97
6.2.2.1.1 Versatility of reporter gene assays and widespread applications in various fields to fuel growth 97
TABLE 29 REPORTER GENE ASSAYS MARKET, BY REGION, 2021–2028 (USD MILLION) 98
TABLE 30 NORTH AMERICA: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 98
TABLE 31 EUROPE: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 99
TABLE 32 ASIA PACIFIC: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 99
TABLE 33 LATIN AMERICA: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 100
TABLE 34 MIDDLE EAST & AFRICA: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 100
6.2.2.2 Cell growth assays 100
6.2.2.2.1 Growing applications of cell viability and cell proliferation assays for assessing cell growth to boost market 100
TABLE 35 CELL GROWTH ASSAYS MARKET, BY REGION, 2021–2028 (USD MILLION) 101
TABLE 36 NORTH AMERICA: CELL GROWTH ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 102
TABLE 37 EUROPE: CELL GROWTH ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 102
TABLE 38 ASIA PACIFIC: CELL GROWTH ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 103
TABLE 39 LATIN AMERICA: CELL GROWTH ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 103
TABLE 40 MIDDLE EAST & AFRICA: CELL GROWTH ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 103
6.2.2.3 Second messenger assays 104
6.2.2.3.1 Growing use of second messenger assays to study cell signaling to fuel growth 104
TABLE 41 SECOND MESSENGER ASSAYS MARKET, BY REGION, 2021–2028 (USD MILLION) 105
TABLE 42 NORTH AMERICA: SECOND MESSENGER ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 105
TABLE 43 EUROPE: SECOND MESSENGER ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 106
TABLE 44 ASIA PACIFIC: SECOND MESSENGER ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 106
TABLE 45 LATIN AMERICA: SECOND MESSENGER ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 107
TABLE 46 MIDDLE EAST & AFRICA: SECOND MESSENGER ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 107
6.2.2.4 Cell death assays 107
6.2.2.4.1 Importance of cell death quantification in drug development to favor growth 107
TABLE 47 CELL DEATH ASSAYS MARKET, BY REGION, 2021–2028 (USD MILLION) 108
TABLE 48 NORTH AMERICA: CELL DEATH ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 108
TABLE 49 EUROPE: CELL DEATH ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 109
TABLE 50 ASIA PACIFIC: CELL DEATH ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 109
TABLE 51 LATIN AMERICA: CELL DEATH ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 109
TABLE 52 MIDDLE EAST & AFRICA: CELL DEATH ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 110
6.2.2.5 Other assay kits 110
TABLE 53 OTHER ASSAY KITS MARKET, BY REGION, 2021–2028 (USD MILLION) 111
TABLE 54 NORTH AMERICA: OTHER ASSAY KITS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 111
TABLE 55 EUROPE: OTHER ASSAY KITS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 112
TABLE 56 ASIA PACIFIC: OTHER ASSAY KITS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 112
TABLE 57 LATIN AMERICA: OTHER ASSAY KITS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 112
TABLE 58 MIDDLE EAST & AFRICA: OTHER ASSAY KITS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 113
6.2.3 MICROPLATES 113
6.2.3.1 Growing demand for microplates in assay development to propel growth 113
TABLE 59 CELL-BASED ASSAYS MARKET FOR MICROPLATES, BY REGION, 2021–2028 (USD MILLION) 114
TABLE 60 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR MICROPLATES, BY COUNTRY, 2021–2028 (USD MILLION) 114
TABLE 61 EUROPE: CELL-BASED ASSAYS MARKET FOR MICROPLATES, BY COUNTRY, 2021–2028 (USD MILLION) 115
TABLE 62 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR MICROPLATES, BY COUNTRY, 2021–2028 (USD MILLION) 115
TABLE 63 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR MICROPLATES, BY COUNTRY, 2021–2028 (USD MILLION) 116
TABLE 64 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR MICROPLATES, BY COUNTRY, 2021–2028 (USD MILLION) 116
6.2.4 CELL LINES 116
TABLE 65 CELL-BASED ASSAYS MARKET FOR CELL LINES, BY REGION, 2021–2028 (USD MILLION) 117
TABLE 66 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY COUNTRY, 2021–2028 (USD MILLION) 117
TABLE 67 EUROPE: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY COUNTRY, 2021–2028 (USD MILLION) 118
TABLE 68 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY COUNTRY, 2021–2028 (USD MILLION) 118
TABLE 69 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY COUNTRY, 2021–2028 (USD MILLION) 119
TABLE 70 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY COUNTRY, 2021–2028 (USD MILLION) 119
TABLE 71 CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2021–2028 (USD MILLION) 119
6.2.4.1 Immortalized cell lines 120
6.2.4.1.1 Wide use of immortalized cell lines to boost market 120
TABLE 72 IMMORTALIZED CELL LINES MARKET, BY REGION, 2021–2028 (USD MILLION) 120
TABLE 73 NORTH AMERICA: IMMORTALIZED CELL LINES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 121
TABLE 74 EUROPE: IMMORTALIZED CELL LINES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 121
TABLE 75 ASIA PACIFIC: IMMORTALIZED CELL LINES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 122
TABLE 76 LATIN AMERICA: IMMORTALIZED CELL LINES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 122
TABLE 77 MIDDLE EAST & AFRICA: IMMORTALIZED CELL LINES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 122
6.2.4.2 Primary cell lines 123
6.2.4.2.1 Valuable tools for cell-based assays to boost demand for primary cell lines 123
TABLE 78 PRIMARY CELL LINES MARKET, BY REGION, 2021–2028 (USD MILLION) 124
TABLE 79 NORTH AMERICA: PRIMARY CELL LINES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 124
TABLE 80 EUROPE: PRIMARY CELL LINES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 125
TABLE 81 ASIA PACIFIC: PRIMARY CELL LINES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 125
TABLE 82 LATIN AMERICA: PRIMARY CELL LINES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 126
TABLE 83 MIDDLE EAST & AFRICA: PRIMARY CELL LINES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 126
6.2.4.3 Stem cell lines 126
6.2.4.3.1 Use of stem cell lines to model wide variety of tissues and diseases to fuel adoption 126
TABLE 84 STEM CELL LINES MARKET, BY REGION, 2021–2028 (USD MILLION) 127
TABLE 85 NORTH AMERICA: STEM CELL LINES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 128
TABLE 86 EUROPE: STEM CELL LINES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 128
TABLE 87 ASIA PACIFIC: STEM CELL LINES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 128
TABLE 88 LATIN AMERICA: STEM CELL LINES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 129
TABLE 89 MIDDLE EAST & AFRICA: STEM CELL LINES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 129
6.2.5 PROBES & LABELS 129
6.2.5.1 Growing need of effective labeling of cells to study cellular events to boost demand 129
TABLE 90 CELL-BASED ASSAYS MARKET FOR PROBES & LABELS, BY REGION, 2021–2028 (USD MILLION) 131
TABLE 91 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR PROBES & LABELS, BY COUNTRY, 2021–2028 (USD MILLION) 131
TABLE 92 EUROPE: CELL-BASED ASSAYS MARKET FOR PROBES & LABELS, BY COUNTRY, 2021–2028 (USD MILLION) 132
TABLE 93 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR PROBES & LABELS, BY COUNTRY, 2021–2028 (USD MILLION) 132
TABLE 94 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR PROBES & LABELS, BY COUNTRY, 2021–2028 (USD MILLION) 133
TABLE 95 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR PROBES & LABELS, BY COUNTRY, 2021–2028 (USD MILLION) 133
6.2.6 OTHER CONSUMABLES 133
TABLE 96 CELL-BASED ASSAYS MARKET FOR OTHER CONSUMABLES, BY REGION, 2021–2028 (USD MILLION) 134
TABLE 97 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION) 134
TABLE 98 EUROPE: CELL-BASED ASSAYS MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION) 135
TABLE 99 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION) 135
TABLE 100 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION) 136
TABLE 101 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION) 136
6.3 INSTRUMENTS & SOFTWARE 136
6.3.1 AUTOMATION IN INSTRUMENTS ALONG WITH ADOPTION OF SOFTWARE TO DRIVE SEGMENTAL GROWTH 136
TABLE 102 CELL-BASED ASSAYS MARKET FOR INSTRUMENTS & SOFTWARE, BY REGION, 2021–2028 (USD MILLION) 138
TABLE 103 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR INSTRUMENTS & SOFTWARE, BY COUNTRY, 2021–2028 (USD MILLION) 138
TABLE 104 EUROPE: CELL-BASED ASSAYS MARKET FOR INSTRUMENTS & SOFTWARE, BY COUNTRY, 2021–2028 (USD MILLION) 139
TABLE 105 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR INSTRUMENTS & SOFTWARE, BY COUNTRY, 2021–2028 (USD MILLION) 139
TABLE 106 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR INSTRUMENTS & SOFTWARE, BY COUNTRY, 2021–2028 (USD MILLION) 140
TABLE 107 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR INSTRUMENTS & SOFTWARE, BY COUNTRY, 2021–2028 (USD MILLION) 140
6.4 SERVICES 140
6.4.1 GROWING NUMBER OF CROS PROVIDING DRUG DISCOVERY AND SCREENING SERVICES TO ACCELERATE GROWTH 140
TABLE 108 CELL-BASED ASSAYS MARKET FOR SERVICES, BY REGION, 2021–2028 (USD MILLION) 141
TABLE 109 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 141
TABLE 110 EUROPE: CELL-BASED ASSAYS MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 142
TABLE 111 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 142
TABLE 112 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 143
TABLE 113 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 143
7 CELL-BASED ASSAYS MARKET, BY APPLICATION 144
7.1 INTRODUCTION 145
TABLE 114 CELL-BASED ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 145
7.2 DRUG DISCOVERY 145
TABLE 115 CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 146
TABLE 116 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 146
TABLE 117 EUROPE: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 147
TABLE 118 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 147
TABLE 119 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 148
TABLE 120 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 148
TABLE 121 CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 148
7.2.1 TOXICITY STUDIES 149
7.2.1.1 Increasing demand for cell-based assays in toxicity testing to fuel growth 149
TABLE 122 CELL-BASED ASSAYS MARKET FOR TOXICITY STUDIES, BY REGION, 2021–2028 (USD MILLION) 150
TABLE 123 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR TOXICITY STUDIES, BY COUNTRY, 2021–2028 (USD MILLION) 150
TABLE 124 EUROPE: CELL-BASED ASSAYS MARKET FOR TOXICITY STUDIES, BY COUNTRY, 2021–2028 (USD MILLION) 151
TABLE 125 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR TOXICITY STUDIES, BY COUNTRY, 2021–2028 (USD MILLION) 151
TABLE 126 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR TOXICITY STUDIES, BY COUNTRY, 2021–2028 (USD MILLION) 152
TABLE 127 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR TOXICITY STUDIES, BY COUNTRY, 2021–2028 (USD MILLION) 152
7.2.2 PHARMACOKINETIC STUDIES 152
7.2.2.1 Growing focus on ADME studies in pharmacokinetics to propel demand for cell-based assays 152
TABLE 128 CELL-BASED ASSAYS MARKET FOR PHARMACOKINETIC STUDIES, BY REGION, 2021–2028 (USD MILLION) 153
TABLE 129 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR PHARMACOKINETIC STUDIES, BY COUNTRY, 2021–2028 (USD MILLION) 154
TABLE 130 EUROPE: CELL-BASED ASSAYS MARKET FOR PHARMACOKINETIC STUDIES, BY COUNTRY, 2021–2028 (USD MILLION) 154
TABLE 131 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR PHARMACOKINETIC STUDIES, BY COUNTRY, 2021–2028 (USD MILLION) 155
TABLE 132 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR PHARMACOKINETIC STUDIES, BY COUNTRY, 2021–2028 (USD MILLION) 155
TABLE 133 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR PHARMACOKINETIC STUDIES, BY COUNTRY, 2021–2028 (USD MILLION) 155
7.2.3 PHARMACODYNAMIC STUDIES 156
7.2.3.1 Advantages of cell-based assays in studying pharmacodynamics to propel growth 156
TABLE 134 CELL-BASED ASSAYS MARKET FOR PHARMACODYNAMIC STUDIES, BY REGION, 2021–2028 (USD MILLION) 156
TABLE 135 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR PHARMACODYNAMIC STUDIES, BY COUNTRY, 2021–2028 (USD MILLION) 157
TABLE 136 EUROPE: CELL-BASED ASSAYS MARKET FOR PHARMACODYNAMIC STUDIES, BY COUNTRY, 2021–2028 (USD MILLION) 157
TABLE 137 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR PHARMACODYNAMIC STUDIES, BY COUNTRY, 2021–2028 (USD MILLION) 158
TABLE 138 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR PHARMACODYNAMIC STUDIES, BY COUNTRY, 2021–2028 (USD MILLION) 158
TABLE 139 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR PHARMACODYNAMIC STUDIES, BY COUNTRY, 2021–2028 (USD MILLION) 158
7.3 BASIC RESEARCH 159
7.3.1 INCREASING FUNDING BY GOVERNMENT INSTITUTES FOR BASIC RESEARCH TO DRIVE DEMAND FOR CELL-BASED ASSAY PRODUCTS & SERVICES 159
TABLE 140 CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 160
TABLE 141 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 160
TABLE 142 EUROPE: CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 161
TABLE 143 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 161
TABLE 144 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 162
TABLE 145 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 162
7.4 OTHER APPLICATIONS 162
TABLE 146 CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 163
TABLE 147 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 163
TABLE 148 EUROPE: CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 164
TABLE 149 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 164
TABLE 150 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 165
TABLE 151 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 165
8 CELL-BASED ASSAYS MARKET, BY END USER 166
8.1 INTRODUCTION 167
TABLE 152 CELL-BASED ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION) 167
8.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES 167
8.2.1 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES TO DOMINATE MARKET DURING FORECAST PERIOD 167
FIGURE 27 RISING GLOBAL PHARMACEUTICAL R&D SPENDING, 2012–2026 168
TABLE 153 CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2021–2028 (USD MILLION) 169
TABLE 154 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 169
TABLE 155 EUROPE: CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 170
TABLE 156 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 170
TABLE 157 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 171
TABLE 158 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 171
8.3 CONTRACT RESEARCH ORGANIZATIONS (CROS) 171
8.3.1 GROWING DEMAND FOR OUTSOURCING TO DRIVE DEMAND FOR CELL-BASED ASSAYS IN CONTRACT RESEARCH ORGANIZATIONS 171
TABLE 159 CELL-BASED ASSAYS MARKET FOR CROS, BY REGION, 2021–2028 (USD MILLION) 172
TABLE 160 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR CROS, BY COUNTRY, 2021–2028 (USD MILLION) 172
TABLE 161 EUROPE: CELL-BASED ASSAYS MARKET FOR CROS, BY COUNTRY, 2021–2028 (USD MILLION) 173
TABLE 162 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR CROS, BY COUNTRY, 2021–2028 (USD MILLION) 173
TABLE 163 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR CROS, BY COUNTRY, 2021–2028 (USD MILLION) 174
TABLE 164 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR CROS, BY COUNTRY, 2021–2028 (USD MILLION) 174
8.4 ACADEMIC & RESEARCH INSTITUTES 174
8.4.1 GROWING FOCUS OF ACADEMIC INSTITUTIONS ON DEVELOPING ASSAYS FOR INNOVATIVE APPLICATIONS TO DRIVE DEMAND 174
TABLE 165 CELL-BASED ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION) 175
TABLE 166 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 175
TABLE 167 EUROPE: CELL-BASED ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 176
TABLE 168 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 176
TABLE 169 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 177
TABLE 170 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 177
9 CELL-BASED ASSAYS MARKET, BY REGION 178
9.1 INTRODUCTION 179
TABLE 171 CELL-BASED ASSAYS MARKET, BY REGION, 2021–2028 (USD MILLION) 179
9.2 NORTH AMERICA 179
FIGURE 28 NORTH AMERICA: CELL-BASED ASSAYS MARKET SNAPSHOT 180
TABLE 172 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 181
TABLE 173 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 181
TABLE 174 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION) 182
TABLE 175 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION) 182
TABLE 176 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2021–2028 (USD MILLION) 183
TABLE 177 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 183
TABLE 178 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 183
TABLE 179 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION) 184
9.2.1 NORTH AMERICA: RECESSION IMPACT 184
9.2.2 US 185
9.2.2.1 US to dominate North American cell-based assays market during forecast period 185
TABLE 180 US: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 186
TABLE 181 US: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION) 186
TABLE 182 US: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION) 187
TABLE 183 US: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2021–2028 (USD MILLION) 187
TABLE 184 US: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 188
TABLE 185 US: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 188
TABLE 186 US: CELL-BASED ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION) 189
9.2.3 CANADA 189
9.2.3.1 Strategic partnerships and collaborations to drive market in Canada 189
TABLE 187 CANADA: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 190
TABLE 188 CANADA: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION) 190
TABLE 189 CANADA: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION) 191
TABLE 190 CANADA: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2021–2028 (USD MILLION) 191
TABLE 191 CANADA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 192
TABLE 192 CANADA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 192
TABLE 193 CANADA: CELL-BASED ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION) 192
9.3 EUROPE 193
TABLE 194 EUROPE:



9.4 ASIA PACIFIC 218
FIGURE 29 ASIA PACIFIC: CELL-BASED ASSAYS MARKET SNAPSHOT 219
TABLE 244 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 220
TABLE 245 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 220
TABLE 246 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION) 221
TABLE 247 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION) 221
TABLE 248 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2021–2028 (USD MILLION) 222
TABLE 249 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 222
TABLE 250 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 222
TABLE 251 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION) 223
9.4.1 ASIA PACIFIC: RECESSION IMPACT 223
9.4.2 CHINA 224
9.4.2.1 Robust pharma industry and presence of key CROs to favor market growth 224
TABLE 252 CHINA: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 224
TABLE 253 CHINA: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION) 225
TABLE 254 CHINA: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION) 225
TABLE 255 CHINA: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2021–2028 (USD MILLION) 226
TABLE 256 CHINA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 226
TABLE 257 CHINA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 226
TABLE 258 CHINA: CELL-BASED ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION) 227
9.4.3 JAPAN 227
9.4.3.1 Government initiatives for drug innovation to support market growth 227
TABLE 259 JAPAN: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 228
TABLE 260 JAPAN: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION) 228
TABLE 261 JAPAN: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION) 229
TABLE 262 JAPAN: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2021–2028 (USD MILLION) 229
TABLE 263 JAPAN: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 230
TABLE 264 JAPAN: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 230
TABLE 265 JAPAN: CELL-BASED ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION) 230
9.4.4 INDIA 231
9.4.4.1 Increasing investments in R&D and funding for life science research to propel market 231
TABLE 266 INDIA: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 231
TABLE 267 INDIA: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION) 232
TABLE 268 INDIA: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION) 232
TABLE 269 INDIA: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2021–2028 (USD MILLION) 233
TABLE 270 INDIA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 233
TABLE 271 INDIA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 233
TABLE 272 INDIA: CELL-BASED ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION) 234
9.4.5 REST OF ASIA PACIFIC 234
TABLE 273 REST OF ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 235
TABLE 274 REST OF ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION) 235
TABLE 275 REST OF ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION) 236
TABLE 276 REST OF ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2021–2028 (USD MILLION) 236
TABLE 277 REST OF ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 237
TABLE 278 REST OF ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 237
TABLE 279 REST OF ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION) 238
9.5 LATIN AMERICA 238
TABLE 280 LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 239
TABLE 281 LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 239
TABLE 282 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION) 240
TABLE 283 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION) 240
TABLE 284 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2021–2028 (USD MILLION) 241
TABLE 285 LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 241
TABLE 286 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 241
TABLE 287 LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION) 242
9.5.1 LATIN AMERICA: RECESSION IMPACT 242
9.5.2 BRAZIL 242
9.5.2.1 Growing research & development activities to support market growth 242
TABLE 288 BRAZIL: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 243
TABLE 289 BRAZIL: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION) 243
TABLE 290 BRAZIL: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION) 244
TABLE 291 BRAZIL: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2021–2028 (USD MILLION) 244
TABLE 292 BRAZIL: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 245
TABLE 293 BRAZIL: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 245
TABLE 294 BRAZIL: CELL-BASED ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION) 245
9.5.3 REST OF LATIN AMERICA 246
TABLE 295 REST OF LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 246
TABLE 296 REST OF LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION) 246
TABLE 297 REST OF LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION) 247
TABLE 298 REST OF LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2021–2028 (USD MILLION) 247
TABLE 299 REST OF LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 248
TABLE 300 REST OF LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 248
TABLE 301 REST OF LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION) 249
9.6 MIDDLE EAST & AFRICA 249
TABLE 302 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 249
TABLE 303 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 250
TABLE 304 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION) 250
TABLE 305 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION) 251
TABLE 306 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2021–2028 (USD MILLION) 251
TABLE 307 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 252
TABLE 308 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 252
TABLE 309 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION) 253
9.6.1 MIDDLE EAST & AFRICA: RECESSION IMPACT 253
9.6.2 MIDDLE EAST 253
9.6.2.1 Growing prevalence of chronic diseases in Middle East to boost growth 253
TABLE 310 MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 254
TABLE 311 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION) 254
TABLE 312 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION) 255
TABLE 313 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2021–2028 (USD MILLION) 255
TABLE 314 MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 256
TABLE 315 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 256
TABLE 316 MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION) 256
9.6.3 AFRICA 257
9.6.3.1 Government initiatives to drive research & development in Africa 257
TABLE 317 AFRICA: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 257
TABLE 318 AFRICA: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2021–2028 (USD MILLION) 258
TABLE 319 AFRICA: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION) 258
TABLE 320 AFRICA: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2021–2028 (USD MILLION) 259
TABLE 321 AFRICA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 259
TABLE 322 AFRICA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 259
TABLE 323 AFRICA: CELL-BASED ASSAYS MARKET, BY END USER, 2021–2028 (USD MILLION) 260
10 COMPETITIVE LANDSCAPE 261
10.1 OVERVIEW 261
10.2 STRATEGIES ADOPTED BY KEY PLAYERS 262
FIGURE 30 STRATEGIES ADOPTED BY KEY PLAYERS IN CELL-BASED ASSAYS MARKET, JANUARY 2020–JUNE 2023 262
10.3 MARKET SHARE ANALYSIS 263
FIGURE 31 CELL-BASED ASSAYS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2022 263
TABLE 324 CELL-BASED ASSAYS MARKET: DEGREE OF COMPETITION 263
10.4 REVENUE SHARE ANALYSIS 265
10.5 COMPANY EVALUATION QUADRANT 265
10.5.1 STARS 266
10.5.2 EMERGING LEADERS 266
10.5.3 PERVASIVE PLAYERS 266
10.5.4 PARTICIPANTS 266
FIGURE 33 CELL-BASED ASSAYS MARKET: COMPANY EVALUATION QUADRANT, 2022 267
10.6 COMPANY EVALUATION QUADRANT FOR START-UPS/SMES 267
10.6.1 PROGRESSIVE COMPANIES 267
10.6.2 STARTING BLOCKS 268
10.6.3 RESPONSIVE COMPANIES 268
10.6.4 DYNAMIC COMPANIES 268
FIGURE 34 CELL-BASED ASSAYS MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2022 268
10.6.4.1 Competitive benchmarking of start-ups/SME players 269
TABLE 325 CELL-BASED ASSAYS MARKET: DETAILED LIST OF KEY START-UPS/SMES 269
TABLE 326 CELL-BASED ASSAYS MARKET: COMPETITIVE BENCHMARKING OF KEY START-UPS/SMES 270
10.7 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS 271
10.7.1 COMPANY FOOTPRINT (25 COMPANIES) 271
TABLE 327 COMPANY FOOTPRINT ANALYSIS OF KEY PLAYERS 271
10.7.2 PRODUCT & SERVICE FOOTPRINT (25 COMPANIES) 272
TABLE 328 PRODUCT & SERVICE FOOTPRINT ANALYSIS OF KEY PLAYERS 272
10.7.3 REGIONAL FOOTPRINT (25 COMPANIES) 273
TABLE 329 REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS 273
10.8 COMPETITIVE SCENARIO AND TRENDS 274
TABLE 330 CELL-BASED ASSAYS MARKET: DEALS, JANUARY 2020–JUNE 2023 274
TABLE 331 CELL-BASED ASSAYS MARKET: PRODUCT & SERVICE LAUNCHES, JANUARY 2020–JUNE 2023 275
TABLE 332 CELL-BASED ASSAYS MARKET: OTHER DEVELOPMENTS, JANUARY 2020–JUNE 2023 275
11 COMPANY PROFILES 277
11.1 KEY PLAYERS 277
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1 DANAHER CORPORATION 277
TABLE 333 DANAHER CORPORATION: BUSINESS OVERVIEW 277
FIGURE 35 DANAHER CORPORATION: COMPANY SNAPSHOT (2022) 278
11.1.2 THERMO FISHER SCIENTIFIC 286
TABLE 334 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW 286
FIGURE 36 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2022) 287
11.1.3 MERCK KGAA 297
TABLE 335 MERCK KGAA: BUSINESS OVERVIEW 297
FIGURE 37 MERCK KGAA: COMPANY SNAPSHOT (2022) 298
11.1.4 BECTON, DICKINSON AND COMPANY 303
TABLE 336 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW 303
FIGURE 38 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022) 304
11.1.5 LONZA GROUP 307
TABLE 337 LONZA GROUP: BUSINESS OVERVIEW 307
FIGURE 39 LONZA GROUP: COMPANY SNAPSHOT (2022) 308
11.1.6 PERKINELMER, INC. 311
TABLE 338 PERKINELMER, INC.: BUSINESS OVERVIEW 311
FIGURE 40 PERKINELMER, INC.: COMPANY SNAPSHOT (2022) 312
11.1.7 CHARLES RIVER LABORATORIES 314
TABLE 339 CHARLES RIVER LABORATORIES: BUSINESS OVERVIEW 314
FIGURE 41 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2022) 315
11.1.8 EUROFINS SCIENTIFIC SE 319
TABLE 340 EUROFINS SCIENTIFIC SE: BUSINESS OVERVIEW 319
FIGURE 42 EUROFINS SCIENTIFIC SE: COMPANY SNAPSHOT (2022) 319
11.1.9 ENZO BIOCHEM, INC. 323
TABLE 341 ENZO BIOCHEM, INC.: BUSINESS OVERVIEW 323
FIGURE 43 ENZO BIOCHEM, INC.: COMPANY SNAPSHOT (2022) 324
11.1.10 CARNA BIOSCIENCES, INC. 328
TABLE 342 CARNA BIOSCIENCES, INC.: BUSINESS OVERVIEW 328
FIGURE 44 CARNA BIOSCIENCES, INC.: COMPANY SNAPSHOT (2022) 329
11.2 OTHER PLAYERS 331
11.2.1 CELL BIOLABS, INC. 331
11.2.2 PROMEGA CORPORATION 332
11.2.3 CELL SIGNALING TECHNOLOGY, INC. 334
11.2.4 BIOAGILYTIX 335
11.2.5 REACTION BIOLOGY CORPORATION 336
11.2.6 AAT BIOQUEST 337
11.2.7 PESTKA BIOMEDICAL LABORATORIES, INC 339
11.2.8 INVIVOGEN 340
11.2.9 CA3 BIOSCIENCES, INC 341
11.2.10 BPS BIOSCIENCE, INC. 342
11.2.11 BELLBROOK LABS, INC. 343
11.2.12 PROFACGEN 343
11.2.13 BMG LABTECH 344
11.2.14 HANUGEN THERAPEUTICS 345
11.2.15 JRS PHARMA 346
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX 347
12.1 DISCUSSION GUIDE 347
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 350
12.3 AVAILABLE CUSTOMIZATIONS 352
12.4 RELATED REPORTS 352
12.5 AUTHOR DETAILS 353